Moleculin Biotech Inc (NASDAQ:MBRX) does about 4.73M shares in volume on a normal day but saw 1215763 shares change hands in the recent trading day. The company now has a market cap of 23.43M USD. Its current market price is $0.78, marking a decrease of -3.34% compared to the previous close of $0.8. The 52 week high reached by this stock is $4.39 whilst the lowest price level in 52 weeks is $0.25.
Moleculin Biotech Inc (MBRX) has a 20-day trading average at $0.5113 and the current price is -82.33% off the 52-week high compared with 210.24% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.6852 and its 200-day simple moving average is $1.4623. If we look at the stock’s price movements over the week, volatility stands at 18.27%, which increases to 19.69% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 63.53 to suggest the stock is neutral.
The consensus objective for the share price is $7.00, suggesting that the stock has a potential upside of 88.86% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 09, 2025 when H.C. Wainwright resumed the stock to “Buy” and issued a price target of $4. Oppenheimer resumed its price target at $14.
The current price level is 51.68%, 13.20%, and -46.96% away from its SMA20, SMA50, and SMA200 respectively, with the MBRX price moving below the 50-day SMA on current market day. Moleculin Biotech Inc (MBRX) stock is up 23.37% over the week and 190.49% over the past month. Its price is -83.18% year-to-date and -54.38% over the past year.
To reach the target analysts have set, the stock logically needs to grow 88.86 percent from here.
Outstanding shares total 30.21M with insiders holding 3.53% of the shares and institutional holders owning 4.89% of the company’s common stock. The company has a return on investment of -6312.23% and return on equity of -214.79%. The beta has a value of 1.37. Price to book ratio is 261.14.
